Updated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences

Rhea-AI Summary

Myriad Genetics (NASDAQ: MYGN), a molecular diagnostic testing and precision medicine company, has announced its participation in two major upcoming healthcare investor conferences. Management will participate in a fireside chat at the BofA Securities 2025 Health Care Conference on May 14, 2025, at 6:00 PM ET, and at the Goldman Sachs 46th Annual Global Healthcare Conference on June 11, 2025, at 2:00 PM ET. Both presentations will be available for viewing through live and archived webcasts on the company's investor relations website at investor.myriad.com.

News Market Reaction – MYGN

+7.03%

+7.03% Session move

In the trading session that priced this news, MYGN gained 7.03%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Correction: Time of BofA Conference

SALT LAKE CITY, May 14, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that management plans to participate in the following investor healthcare conferences:

• The BofA Securities 2025 Health Care Conference – fireside chat at 6:00 pm ET (updated) on Wednesday, May 14, 2025.
• Goldman Sachs 46^th Annual Global Healthcare Conference – fireside chat at 2:00 pm ET on Wednesday, June 11, 2025.

Live and archived webcasts of all presentations can be viewed at investor.myriad.com.

About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers molecular tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.

Investor Contact 
Matt Scalo 
(801) 584-3532 
IR@myriad.com 

Media Contact 
Kate Schraml
(224) 875-4493
PR@myriad.com  

FAQ

When is Myriad Genetics (MYGN) presenting at the BofA Securities Healthcare Conference 2025?

Myriad Genetics will participate in a fireside chat at the BofA Securities Healthcare Conference on Wednesday, May 14, 2025, at 6:00 PM ET.

What time is Myriad Genetics (MYGN) presenting at the Goldman Sachs Healthcare Conference 2025?

Myriad Genetics will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference on Wednesday, June 11, 2025, at 2:00 PM ET.

Where can I watch Myriad Genetics (MYGN) investor conference presentations?

Live and archived webcasts of Myriad Genetics' presentations can be viewed on their investor relations website at investor.myriad.com.

Which investor healthcare conferences is Myriad Genetics (MYGN) attending in 2025?

Myriad Genetics is attending the BofA Securities Health Care Conference in May 2025 and the Goldman Sachs 46th Annual Global Healthcare Conference in June 2025.